Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 649 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow

Kelwade Jayant, Sethi Bipin Kumar, Vaseem Ayesha, Nagesh V Sri

Year : 2014| Volume: 18| Issue : 6 | Page no: 874-875

   This article has been cited by
1 Use of SGLT2 inhibitors during Ramadan: An expert panel statement
Mohamed Hassanein,Alaaeldeen Bashier,Hoosen Randeree,Megahed Abouelmagd,Waleed AlBaker,Bachar Afandi,Omar Abu Hijleh,Inass Shaltout,Magdy EI-Sharkawy,Selcuk Dagdelen,Samir Assaad Khalil
Diabetes Research and Clinical Practice. 2020; 169: 108465
[Pubmed]  [Google Scholar] [DOI]
2 Evolving physicians’ perceptions and practices regarding use of SGLT2 inhibitors for type 2 diabetes during Ramadan fasting
Salem A. Beshyah,Khadija Hafidh,Tariq Gul Shaikh
Diabetes Research and Clinical Practice. 2020; 168: 108389
[Pubmed]  [Google Scholar] [DOI]
3 Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients
Ehab Mudher Mikhael
Journal of Diabetes Research. 2016; 2016: 1
[Pubmed]  [Google Scholar] [DOI]


Read this article